CRSP Stock
CRISPR Therapeutics AG (CRSP) poses a Brand-New Opportunity for Investors with beta value of 1.70
Sana Meer
As on Wednesday, CRISPR Therapeutics AG (NASDAQ: CRSP) got off with the flyer as it spiked 8.55% to $55.99, before ...
Can CRISPR Therapeutics AG’s (CRSP) drop of -4.70% in a week be considered a lucky break?
Shaun Noe
On Friday, CRISPR Therapeutics AG (NASDAQ: CRSP) was 2.78% up from the session before settling in for the closing price ...
CRISPR Therapeutics AG (CRSP) is expecting 32.33% growth in the next quarter: What can investors do to maximize their returns?
Steve Mayer
On Friday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened lower -6.98% from the last session, before settling in for the closing ...
CRISPR Therapeutics AG (CRSP) volume hits 1.95 million: A New Opening for Investors
Sana Meer
Witnessing the stock’s movement on the chart, on N/A, CRISPR Therapeutics AG (NASDAQ: CRSP) set off with pace as it ...
